<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">tiblj</journal-id><journal-title-group><journal-title xml:lang="ru">Туберкулез и болезни легких</journal-title><trans-title-group xml:lang="en"><trans-title>Tuberculosis and Lung Diseases</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2075-1230</issn><issn pub-type="epub">2542-1506</issn><publisher><publisher-name>Медицинские знания и технологии</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.58838/2075-1230-2023-101-5-36-44</article-id><article-id custom-type="elpub" pub-id-type="custom">tiblj-1766</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Особенности течения и лечения туберкулеза органов дыхания у женщин во время беременности и послеродовом периоде. Перинатальные исходы</article-title><trans-title-group xml:lang="en"><trans-title>Specific Features of the Course and Treatment of Respiratory Tuberculosis in Women during Pregnancy and Postpartum Period. Perinatal Outcomes</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5233-3515</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каюкова</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kayukova</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каюкова Светлана Ивановна, Д.м.н., ведущий научный сотрудникотдела иммунологии</p><p>Тел.: +7 (915) 396-85-34</p><p>107564, г. Москва, Яузская аллея, д.2</p></bio><bio xml:lang="en"><p>Sveltana I. Kayukova, Doctor of Medical Sciences, Leading Researcher of Immunology Department</p><p>Phone: +7 (915) 396-85-34</p><p>2, Yauzskaya Alleya, Moscow, 107564</p></bio><email xlink:type="simple">kajukovalnp@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-8037-249X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Улюмджиева</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ulyumdzhieva</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Улюмджиева Валентина Александровна, Аспирант</p><p>Тел.: +7 ( 937) 196-92-22</p><p>107564, г. Москва, Яузская аллея, д.2</p></bio><bio xml:lang="en"><p>Valentina A. Ulyumdzhieva, Post-Graduate Student</p><p>Phone: +7 ( 937) 196-92-22</p><p>2, Yauzskaya Alleya, Moscow, 107564</p></bio><email xlink:type="simple">amulek@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Идрисова</surname><given-names>Л. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Idrisova</surname><given-names>L. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Идрисова Лилия Султановна, К.м.н., главный врач</p><p>Тел.: +7 (916) 911-27-26</p><p>0000-0002-5140-0245</p><p>364024, Чеченская республка, г. Грозный, ул. С.Ш. Лорсанова, д.1</p></bio><bio xml:lang="en"><p>Lilya S. Idrisova, Candidate of Medical Sciences, Head Physician</p><p>Phone: +7 (916) 911-27-26</p><p>1, S. Sh. Lorsanova St., Grozny, the Chechen Republic, 364024</p></bio><email xlink:type="simple">dr.idrisova1@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7800-8158</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карпина</surname><given-names>Н. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Karpina</surname><given-names>N. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Карпина Наталья Леонидовна, К.м.н., заместитель директора по науке</p><p>Тел.: +7 (916) 097-36-96</p><p>107564, г. Москва, Яузская аллея, д.2</p></bio><bio xml:lang="en"><p>Nataliya L. Karpina, Candidate of Medical Sciences, Deputy Director for Research</p><p>Phone: +7 (916) 097-36-96</p><p>2, Yauzskaya Alleya, Moscow, 107564</p></bio><email xlink:type="simple">natalya-karpina@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Центральный НИИ туберкулеза»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central Tuberculosis Research Institute</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУ «РКЦОЗМиР имени Аймани Кадыровой»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Republican Clinical Center for Mother and Child Health Named after Aymani Kadyrova</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>24</day><month>12</month><year>2023</year></pub-date><volume>101</volume><issue>5</issue><fpage>36</fpage><lpage>44</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Каюкова С.И., Улюмджиева В.А., Идрисова Л.С., Карпина Н.Л., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Каюкова С.И., Улюмджиева В.А., Идрисова Л.С., Карпина Н.Л.</copyright-holder><copyright-holder xml:lang="en">Kayukova S.I., Ulyumdzhieva V.A., Idrisova L.S., Karpina N.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.tibl-journal.com/jour/article/view/1766">https://www.tibl-journal.com/jour/article/view/1766</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования: изучить особенности течения, эффективность лечения туберкулеза органов дыхания во время беременности и послеродовом периоде, а также оценить влияние туберкулеза на перинатальные исходы.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. За период 2010-2022гг. на базе ФГБНУ «ЦНИИТ» проведено ретроспективно-проспективное «случай-контроль» исследование 164 пациенток репродуктивного возраста. Было сформировано две группы: группа «Случай» – 82 женщины с сочетанием ТОД и беременности; группа «Контроль» – 82 пациентки с наличием ТОД, без беременности.</p></sec><sec><title>Результаты исследования</title><p>Результаты исследования. В обеих группах чаще регистрировали впервые выявленный ТОД по сравнению с рецидивами. Отличительными особенностями ТОД у беременных по сравнению с женщинами без беременности являлись преобладание доли широкой лекарственной устойчивости M. tuberculosis – 55,5% против 31,7% (p&lt;0,05) соответственно; меньшая частота деструкции легочной ткани – 18,3% против 32,9% (р≤0,05); более высокая частота формирования каверн – 80% и 40,7% (р≤0,05) и осложнений ТОД – 25,6% и 12,2% (р≤0,03) соответственно. Установлена высокая эффективность лечения ТОД по окончании фазы интенсивной терапии как в группе «Случай», так и в группе «Контроль» в виде купирования клинической симптоматики и прекращения бактериовыделения. У пациенток группы «Случай» отмечали более длительный период до абациллирования и низкий показатель закрытия полостей распада (каверн). Беременность у женщин группы «Случай» в 75,6% наблюдений закончилась родами с благоприятными перинатальными исходами.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>The objective</title><p>The objective: to study specific features of the respiratory tuberculosis course and effectiveness of its treatment during pregnancy and postpartum period, and to evaluate the impact of tuberculosis on perinatal outcomes.</p></sec><sec><title>Subjects and Methods</title><p>Subjects and Methods. In 2010 - 2022, a retrospective-prospective case-control study enrolling 164 patients of reproductive age was conducted in Central Tuberculosis Research Institute. Two groups were formed: Case Group included 82 pregnant women with respiratory tuberculosis; Control Group included 82 non-pregnant patients with respiratory tuberculosis.</p></sec><sec><title>Results</title><p>Results. In both groups, new cases of respiratory tuberculosis were notified more often versus relapses. Distinctive features of respiratory tuberculosis in pregnant women versus the non-pregnant were as follows: the predominance of the proportion of extensive drug resistant M. tuberculosis – 55.5% versus 31.7% (p&lt;0.05), respectively; lower frequency of lung tissue destruction – 18.3% versus 32.9% (p≤0.05); higher incidence of cavities - 80% and 40.7% (p≤0.05) and complications of respiratory tuberculosis – 25.6% versus 12.2% (p≤0.03), respectively. The high effectiveness of respiratory tuberculosis treatment such as relief of clinical symptoms and sputum conversion was achieved at the end of the intensive therapy phase both in Case Group and Control Group. Longer time until sputum conversion and lower rate of cavity healing were reported in the patients from Case Group. In 75.6% of pregnant women from Case Group there was a delivery with favorable perinatal outcomes.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>туберкулез</kwd><kwd>беременность</kwd><kwd>химиотерапия</kwd><kwd>новорожденные</kwd></kwd-group><kwd-group xml:lang="en"><kwd>tuberculosis</kwd><kwd>pregnancy</kwd><kwd>chemotherapy</kwd><kwd>newborns</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Нестеренко А.В., Зимина В.Н., Белобородова Е.Н., Карпина Н.Л., Каюкова С.И. Эффективность лечения туберкулеза у беременных в сравнении с больными туберкулезом без беременности // Туберкулез и болезни легких. – 2018. – Т. 96, №11. – С.52-59. https://doi.org/10.21292/2075-1230-2018-96-11-52-59.</mixed-citation><mixed-citation xml:lang="en">Nesterenko A.V., Zimina V.N., Beloborodova E.N., Karpina N.L., Kayukova S.I. Effectiveness of tuberculosis treatment in the pregnant tuberculosis patients versus those nonpregnant. Tuberculosis and Lung Diseases, 2018, vol. 96, no. 11, pp. 52-59. (In Russ.) https://doi.org/10.21292/2075-1230-2018-96-11-52-59.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Рейхруд Т.А., Кульчавеня Е.В., Мышкова Е.П., Жукова И.И., Жукова Е.М. Туберкулез и беременность // Акушерство и гинекология – 2017. - №10 – С.124-129. - https://doi.org/10.18565/aig.2017.10.124-129.</mixed-citation><mixed-citation xml:lang="en">Reykhrud T.A., Kulchavenya E.V., Myshkova E.P., Zhukova I.I., Zhukova E.M. Tuberculosis and pregnancy. Аkusherstvo i Ginekologiya, 2017, no. 10, pp. 124-129. (In Russ.) https://doi.org/10.18565/aig.2017.10.124-129.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Туберкулез органов дыхания. Руководство для врачей под редакцией А.Э. Эргешова. - Галлея Принт: Москва – 2017.– 523с.</mixed-citation><mixed-citation xml:lang="en">Tuberkulez organov dykhaniya. Rukovodstvo dlya vrachey pod redaktsiyey A.E. Ergeshova. [Respiratory tuberculosis. Egreshov Guide for Doctors]. Galleya Print Publ., Moscow, 2017, 523 p.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Федеральные клинические рекомендации по диагностике и лечению туберкулеза органов дыхания. Российское общество фтизиатров, Москва, 2014г., 43с./ http://roftb.ru.</mixed-citation><mixed-citation xml:lang="en">Federalnye klinicheskie rekomendatsii po diagnostike i lecheniyu tuberkuleza organov dykhaniya. [Federal recommendations for diagnostics and treatment of respiratory tuberculosis]. Rossiyskoe Obschestvo Ftiziatrov Publ., Moscow, 2014, 43 p. https://roftb.ru.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Alene K.A., Murray M.B., van de Water B.J., Becerra M.C., Atalell K.A., Nicol M.P., Clements ACA. Treatment Outcomes Among Pregnant Patients With Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-analysis // JAMA Netw Open. – 2022. Vol.5, № 6. – Р. e2216527. https://doi.org/10.1001/jamanetworkopen.2022.16527</mixed-citation><mixed-citation xml:lang="en">Alene K.A., Murray M.B., van de Water B.J., Becerra M.C., Atalell K.A., Nicol M.P., Clements ACA. Treatment Outcomes Among Pregnant Patients With Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-analysis. JAMA Netw Open. – 2022. Vol.5, № 6. –Р. e2216527. https://doi.org/10.1001/jamanetworkopen.2022.16527</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Esmail A., Sabur N.F., Okpechi I., Dheda K. Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill // J. Thorac. Dis. – 2018. – Vol.10, № 5. – Р. 3102–3118. https://doi.org/10.21037/jtd.2018.05.11.</mixed-citation><mixed-citation xml:lang="en">Esmail A., Sabur N.F., Okpechi I., Dheda K. Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill. J. Thorac. Dis. – 2018. – Vol.10, № 5. – Р. 3102–3118. https://doi.org/10.21037/jtd.2018.05.11.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mathad J.S., Yadav S., Vaidyanathan A., Gupta A., LaCourse S.M. Tuberculosis Infection in Pregnant People: Current Practices and Research Priorities. // Pathogens. – 2022. – Vol.11, №12. – Р. 1481. https://doi.org/10.3390/pathogens11121481.</mixed-citation><mixed-citation xml:lang="en">Mathad J.S., Yadav S., Vaidyanathan A., Gupta A., LaCourse S.M. Tuberculosis Infection in Pregnant People: Current Practices and Research Priorities. Pathogens, 2022, vol. 11, no. 12, pp. 1481. https://doi.org/10.3390/pathogens11121481.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Miele K., Bamrah Morris S., Tepper N.K. Tuberculosis in pregnancy // Obstet Gynecol. – 2020. – Vol.135, №6. –Р. 1444–1453. https://doi.org/ 10.1097/AOG.0000000000003890.</mixed-citation><mixed-citation xml:lang="en">Miele K., Bamrah Morris S., Tepper N.K. Tuberculosis in pregnancy. Obstet Gynecol., 2020, vol. 135, no. 6,pp. 1444–1453. https://doi.org/10.1097/AOG.0000000000003890.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Pop L.G., Bacalbasa N., Suciu I.D., Ionescu P., Toader O.D. Tuberculosis in pregnancy // J. Med. Life. –2021. – Vol. 14, № 2. – Р.165–169. https://doi.org/10.25122/jml-2021-0001.</mixed-citation><mixed-citation xml:lang="en">Pop L.G., Bacalbasa N., Suciu I.D., Ionescu P., Toader O.D. Tuberculosis in pregnancy. J. Med. Life, 2021, vol. 14, no. 2, pp. 165–169. https://doi.org/10.25122/jml-2021-0001.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Snow K.J., Bekker A., Huang G.K., Graham S.M. Tuberculosis in pregnant women and neonates: A meta-review of current evidence // Paediatric Respiratory Reviews. –2020. – Vol. 36. – P. 27-32. https://doi.org/10.1016/j.prrv.2020.02.001.</mixed-citation><mixed-citation xml:lang="en">Snow K.J., Bekker A., Huang G.K., Graham S.M. Tuberculosis in pregnant women and neonates: A meta-review of current evidence. Paediatric Respiratory Reviews, 2020, vol. 36, pp. 27-32. https://doi.org/10.1016/j.prrv.2020.02.001.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sobhy S., Babiker ZOE., Zamora J., Khan K.S., Kunst H. Maternal and perinatal mortality and morbidity associated with tuberculosis during pregnancy and the postpartum period: a systematic review and meta-analysis. // BJOG. – 2017. – Vol.124,№ 5. – Р.727-733. https://doi.org/10.1111/1471-0528.14408www.bjog.orgSystematic review.</mixed-citation><mixed-citation xml:lang="en">Sobhy S., Babiker ZOE., Zamora J., Khan K.S., Kunst H. Maternal and perinatal mortality and morbidity associated with tuberculosis during pregnancy and the postpartum period: a systematic review and meta-analysis. BJOG, 2017, vol. 124, no. 5, pp.727-733. https://doi.org/10.1111/1471-0528.14408www.bjog.orgSystematic review.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
